Skip to search.
 FTSE 100 Up 0.62%
Streaming
Ticker Tape: On

More On PXSLY

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Pharmaxis Ltd. (PXSLY)

-Other OTC
1.20 0.00(0.00%) 15 Apr 19:20
Add to Portfolio
Prev Close:1.20
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:32.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.20 - 5.91
Volume:0
Avg Vol (3m):194
Market Cap:24.72m
P/E (ttm):N/A
EPS (ttm):-2.17
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for PXSLY at this time.

Comparison

Symbol% ChgMkt Cap
PXSLY 0.00%24.72m
AZNDown 0.06%79.82b
DSCODown 3.06%160.92m
MRKUp 0.37%166.06b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-09) :N/A
Quarterly EPS Est (Jun-09) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pharmaxis Ltd, a pharmaceutical company, is engaged in the research, development, and commercialization of human healthcare products for the treatment and management of respiratory diseases in Australia, European Union, Korea, and the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback